Fresenius SE & Co. KGaA



 


All - 2008

23.12.2008   Phase II study shows trifunctional antibody Removab® (catumaxomab) well tolerated in treatment of gastric cancer
  PDF Text as PDF file
22.12.2008   HELIOS awarded two hospital privatization projects in Germany
  PDF Text as PDF file
11.12.2008   Fresenius Medical Care’s peritoneal dialysis products certified by Nordic Ecolabel – First health care company with ecolabelled products
  PDF Text as PDF file
02.12.2008   Capital Market Day: Fresenius Helios and Fresenius Vamed poised for continued growth
  PDF Text as PDF file
19.11.2008   Method to diagnose atrial fibrillation wins Fresenius Inventors’ Prize 2008
  PDF Text as PDF file
06.11.2008   Tenth Fresenius Inventors’ Fair to showcase ideas from researchers and inventors at MEDICA
  PDF Text as PDF file
04.11.2008   Fresenius SE: Q1-3/2008 - Strong growth continued; sales outlook raised
  PDF Text as PDF file
04.11.2008   Fresenius Medical Care Reports Strong Third Quarter and Nine Months Results; Confirms Outlook for 2008
  PDF Text as PDF file
30.09.2008   Syndicated Credit Facilities for APP Pharmaceuticals acquisition financing increased by US$ 500 million due to strong demand
  PDF Text as PDF file
16.09.2008   Fresenius Medical Care Announces Closing of the U.S. License Agreement for Intravenous Iron Products
  PDF Text as PDF file
10.09.2008   Fresenius closes APP acquisition
  PDF Text as PDF file
02.09.2008   Fresenius and APP Pharmaceuticals Announce Clearance of APP Acquisition by U.S. Federal Trade Commission
  PDF Text as PDF file
28.08.2008   Moody’s confirms Fresenius SE’s Ba1 rating
  PDF Text as PDF file
12.08.2008   Fresenius SE successfully completes capital increase
  PDF Text as PDF file
11.08.2008   Acquisition of Dabur Pharma successfully closed
  PDF Text as PDF file
11.08.2008   Substantial oversubscription in first phase of syndication of US$ 2,400 million Senior Secured Credit Facilities
  PDF Text as PDF file
11.08.2008   Fresenius resolves on capital increase
  PDF Text as PDF file
30.07.2008   Fresenius SE: First half 2008 - Strong financial results
  PDF Text as PDF file
30.07.2008   Fresenius Medical Care Confirms Outlook for 2008 - Reports Strong Second Quarter and Half Year Results
  PDF Text as PDF file
17.07.2008   Strong financial results in the first half of 2008
  PDF Text as PDF file
17.07.2008   Fresenius Medical Care Reports Preliminary Second Quarter and First Six Months 2008 Results
  PDF Text as PDF file
17.07.2008   Issuance of mandatory exchangeable bonds, exchangeable into ordinary shares of Fresenius Medical Care AG & Co. KGaA
  PDF Text as PDF file
17.07.2008   Fresenius SE successfully executes offering of € 554 million mandatory exchangeable bonds, exchangeable into ordinary shares of Fresenius Medical Care
  PDF Text as PDF file
09.07.2008   Fresenius Medical Care Signs Agreements for Intravenous Iron Products
  PDF Text as PDF file
07.07.2008   Fresenius Kabi to acquire APP Pharmaceuticals – entry into North American I.V. generics market provides excellent growth opportunities
  PDF Text as PDF file
03.07.2008   International forum for good ideas: Fresenius Inventors’ Fair turns 10 – Applications now accepted
  PDF Text as PDF file
06.06.2008   Fresenius Group donates over US$ 1.5 million in aid for victims of earthquake in China
  PDF Text as PDF file
21.05.2008   Annual General Meeting of Fresenius SE: Fresenius Confirms Positive Outlook for 2008 – 15th Consecutive Dividend Increase Approved
20.05.2008   Moody's Rating of Fresenius Medical Care AG & Co. KGaA upgraded to Ba1
  PDF Text as PDF file
20.05.2008   Moody’s upgrades rating of Fresenius SE to Ba1
  PDF Text as PDF file
20.05.2008   Fresenius Medical Care Reports Strong Start for 2008 - Shareholders Approve Eleventh Consecutive Annual Dividend Increase
  PDF Text as PDF file
30.04.2008   Fresenius SE: Q1 2008 - Successful start into 2008
30.04.2008   Fresenius Medical Care Reports Strong Start For 2008 and Confirms Outlook for Full Year
  PDF Text as PDF file
20.04.2008   Fresenius Kabi strengthens its position in i.v. drugs by acquiring Dabur Pharma, a leading manufacturer of oncology generics
  PDF Text as PDF file
07.04.2008   Fresenius Medical Care announces status in Patent Case
  PDF Text as PDF file
02.04.2008   Fresenius Medical Care Announces upgraded Rating of Unsecured Debt Issues by Standard & Poor’s
  PDF Text as PDF file
06.03.2008   Fresenius Medical Care Expands Dialyzer Production Capacity at St. Wendel, Germany
20.02.2008   Fresenius achieves record financial results in 2007 - positive outlook for 2008
  PDF Text as PDF file
20.02.2008   Fresenius Medical Care Reports Excellent Fourth Quarter and Full Year 2007 Results and Provides Strong Outlook for 2008
  PDF Text as PDF file
29.01.2008   Portugal to Introduce a Bundled Rate for Hemodialysis Treatment
  PDF Text as PDF file
25.01.2008   Fresenius Medical Care Extends Senior Note Exchange Offer
  PDF Text as PDF file
11.01.2008   Fresenius Medical Care Selected To Provide Dialysis Care to More than 400 Patients in the U.K.
  PDF Text as PDF file